AU3673500A - Fine particles targeting cells and process for producing the same - Google Patents

Fine particles targeting cells and process for producing the same

Info

Publication number
AU3673500A
AU3673500A AU36735/00A AU3673500A AU3673500A AU 3673500 A AU3673500 A AU 3673500A AU 36735/00 A AU36735/00 A AU 36735/00A AU 3673500 A AU3673500 A AU 3673500A AU 3673500 A AU3673500 A AU 3673500A
Authority
AU
Australia
Prior art keywords
producing
same
fine particles
targeting cells
particles targeting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36735/00A
Inventor
Kazuo Maruyama
Hisae Niki
Tomoko Saisho
Toshiaki Tagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Publication of AU3673500A publication Critical patent/AU3673500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • A61K47/6913—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome the liposome being modified on its surface by an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
AU36735/00A 1999-04-08 2000-04-07 Fine particles targeting cells and process for producing the same Abandoned AU3673500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10102099 1999-04-08
JP11/101020 1999-04-08
PCT/JP2000/002272 WO2000061114A1 (en) 1999-04-08 2000-04-07 Fine particles targeting cells and process for producing the same

Publications (1)

Publication Number Publication Date
AU3673500A true AU3673500A (en) 2000-11-14

Family

ID=14289532

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36735/00A Abandoned AU3673500A (en) 1999-04-08 2000-04-07 Fine particles targeting cells and process for producing the same

Country Status (2)

Country Link
AU (1) AU3673500A (en)
WO (1) WO2000061114A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915074D0 (en) * 1999-06-28 1999-08-25 Cortecs Plc Ligand-binding composition
JP2006089471A (en) * 2004-08-26 2006-04-06 National Institute Of Advanced Industrial & Technology Use of antimortalin 2 antibody and functional nucleic acid in treatment of cancer
CA2609817A1 (en) * 2005-05-26 2006-11-30 Mebiopharm Co., Ltd. Gene transfer method
JP4881327B2 (en) * 2006-01-31 2012-02-22 大鵬薬品工業株式会社 Liposome preparation of antitumor active substance
EP3908325A1 (en) * 2019-01-07 2021-11-17 Ucl Business Ltd Polymersomes functionalised with multiple ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
JPH09110722A (en) * 1995-10-20 1997-04-28 Toray Ind Inc Immunoliposome for transducing tumorous cell of antitumor active substance and its preparation

Also Published As

Publication number Publication date
WO2000061114A1 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
AU8997098A (en) Propylene copolymer and process for the production thereof
AU4467801A (en) Chlamydospores and process for producing the same
AU2855499A (en) Oxirane derivatives and process for producing the same
AU1351299A (en) Detergent particles and method for producing the same
AU1303801A (en) Transplant material and process for producing the same
AU2003284575A1 (en) Fine composite particle and process for producing the same
AU2000273206A1 (en) Photocatalyst-bearing material and method of producing the same
AU6228699A (en) Process for producing spherical fine particles containing drug
AU6678100A (en) Process for producing thermoelectric material and thermoelectric material thereof
AU1413701A (en) Porous beads and process for producing the same
AU6067200A (en) Systems and methods for producing and using fine particle materials
AU1306601A (en) Chemically modified supports and process for producing the same
AU2144900A (en) Substantially spherical magneto-plumbite ferrite particles and methods for producing and media employing the same
AU1683499A (en) Bilberry-containing drinks and process for producing the same
MXPA01012658A (en) Methods for coating particles and particles produced thereby.
AU7807800A (en) Filter materials and methods for the production thereof
AU3673500A (en) Fine particles targeting cells and process for producing the same
AU5057600A (en) Component and method for the production thereof
AU5625700A (en) Detergent particles and processes for making them
AU7563800A (en) Marsh-mallow and the marsh-mallow production technique
AU2547399A (en) Pyridone derivatives and process for producing the same
AU3193200A (en) Tablets and process for producing the same
AU1734801A (en) Processes for producing tetrahydropyranyl-4-sulfonate and 4-aminotetrahydropyrancompound
HUP0105166A3 (en) Substances wk-5344a and wk-5344b and process for producing the same
AU1653200A (en) Polymer-containing particle and process for the preparation thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase